Re-sterilization the key to duodenoscope market in 2020, says GlobalData

Re-sterilization the key to duodenoscope market in 2020, says GlobalData

Press releases may be edited for formatting or style | December 26, 2019 Endoscopy
Flexible-video duodenoscopes now dominate this scope market, having taken over from fiber-based variants, and non-video scopes are mostly obsolete, says Globaldata, a leading data and analytics company.

Eric Chapman, Medical Devices Analyst at GlobalData, comments: "In December 2019, the US Food and Drug Administration (FDA) announced that it had approved the first fully disposable duodenoscope, manufactured by Boston Scientific. The scope, referred to as the EXALT Model D Single-Use Duodenoscope, was given Breakthrough Device Designation as it is the first and only single-use duodenoscope on the market approved in the US.

"The EXALT Single-Use Duodenoscope will be safer to use, since this device will not need to be reprocessed. Traditional duodenoscopes are used on multiple patients and need to be sterilized between uses. Improper sterilization can result in the spread of infection with detrimental outcomes to patients. This is especially true for duodenoscopes, because they have many small parts that are difficult to clean."

Servicing GE/Siemens Nuclear Medicine equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.

GlobalData estimates that the global market for duodenoscopes was worth over $360m in 2019, with positive growth expected over the next ten years.

Chapman continued: "The introduction of Boston Scientific's EXALT single-Use Duodenoscope in 2020 is expected to act as a major disruptor to the duodenoscope market, resulting in a rapid rise of Boston Scientific's market share. Companies that manufacture duodenoscopes should expedite research and development related to the ease of re-sterilization, so that they can remain competitive."

About GlobalData
4,000 of the world's largest companies, including over 70% of FTSE 100 and 60% of Fortune 100 companies, make more timely and better business decisions thanks to GlobalData's unique data, expert analysis and innovative solutions, all in one platform. GlobalData's mission is to help our clients decode the future to be more successful and innovative across a range of industries, including the healthcare, consumer, retail, financial, technology and professional services sectors.

You Must Be Logged In To Post A Comment